Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma
The DOI matches its Crossref record; 46 of the 48 references it cites were found in a registry or an index.
Abstract
Retinoblastoma clinical observations revealed the role of tumor suppressor genes in human cancer, Knudson's 'two-hit' model of cancer induction. We now demonstrate that loss of both RB1 tumor suppressor gene alleles initiates quiescent RB1(-/-) retinomas with low level genomic instability and high expression of the senescence-associated proteins p16(INK4a) and p130. Although retinomas can remain unchanged throughout life, highly proliferative, clonal and aneuploid retinoblastomas commonly emerge, exhibiting altered gene copy number and expression of oncogenes (MYCN, E2F3, DEK, KIF14 and MDM4) and tumor suppressor genes (CDH11, p75(NTR)) and reduced expression of p16(INK4a) and p130. We suggest that RB1 inactivation in developing retina induces genomic instability, but senescence can block transformation at the stage of retinoma. However, stable retinoma is rarely clinically observed because progressive genomic instability commonly leads to highly proliferative retinoblastoma.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“it is well-accepted that loss of RB is the initiating event in these familial retinal tumours, as well as in sporadic cases15–17.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [17]
In the citing paper
“It has been suggested that this type of chromosomal instability is linked to the progression of benign eye lesions to malignant retinoblastoma17.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [17]
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P. (1986) · Nature · doi:10.1038/323643a0 · Cited by 2,948
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
Oncogene-induced senescence as an initial barrier in lymphoma development
Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2005) · Nature · doi:10.1038/nature03841 · Cited by 1,220
Inactivation of the p53 pathway in retinoblastoma
Laurie, N. A., Donovan, S. L., Shih, C.-S., Zhang, J., Mills, N., Fuller, C., Teunisse, A., Lam, S., Ramos, Y., Mohan, A., et al. (2006) · Nature · doi:10.1038/nature05194 · Cited by 595
Hernando, E., Nahlé, Z., Juan, G., Diaz-Rodriguez, E., Alaminos, M., Hemann, M., Michel, L., Mittal, V., Gerald, W., Benezra, R., et al. (2004) · Nature · doi:10.1038/nature02820 · Cited by 562
The natural history of incidentally detected small renal masses
Volpe, A., Panzarella, T., Rendon, R. A., Haider, M. A., Kondylis, F. I., & Jewett, M. A. S. (2004) · Cancer · doi:10.1002/cncr.20025 · Cited by 526
Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene
Stolle, C. A., Glenn, G. M., Zbar, B., Humphrey, J. S., Choyke, P. L., Walther, M. M., Pack, S., Hurley, K., Andrey, C., Klausner, R. D., et al. (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)12:6<431::aid-humu10>3.0.co;2-y · Cited by 477
Chemotherapy With Focal Therapy Can Cure Intraocular Retinoblastoma Without Radiotherapy
Gallie, B. L. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100140521001 · Cited by 416
Self-citation
Research works printed but not linked: 2
- Radnot, 1977, [Elements of photoreceptors in retinoblastomas (author's transl)], Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol., 202, 63
- Yilmaz, 1998, Twelve novel RB1 gene mutations in patients with hereditary retinoblastoma. Mutations in brief no. 206. Online, Hum. Mutat., 12, 434, 10.1002/(SICI)1098-1004(1998)12:6<434::AID-HUMU16>3.0.CO;2-7 · DOI · Paper page
Cited by
Items 101–200 of 349
High resolution SNP array profiling identifies variability in retinoblastoma genome stability
Mol, B. M., Massink, M. P. G., van der Hout, A. H., Dommering, C. J., Zaman, J. M. A., Bosscha, M. I., Kors, W. A., Meijers-Heijboer, H. E. J., Kaspers, G. J. L., Riele, H. T., et al. (2013) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22111 · Cited by 34
“…loss of RB1 leads to chromosomal instability and acquirement of additional copy number changes are required for the development of retinoblastoma (Dimaras et al., 2008; Manning et al., 2010), a recent paper by Zhang et al. (2012), reporting a high resolution genomic study involving next…”
BackgroundInfluentialGenetic Variations Strongly Influence Phenotypic Outcome in the Mouse Retina
Jelcick, A. S., Yuan, Y., Leehy, B. D., Cox, L. C., Silveira, A. C., Qiu, F., Schenk, S., Sachs, A. J., Morrison, M. A., Nystuen, A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021858 · Cited by 33
“Interestingly, genes showing both strain specific and temporal variation include genes which have been implicated in retinoblastoma (RBL1; [24]), focal retinal ganglion cell loss (THRAP3; [25]), and retinal development (NCOA2; [26], CRABP1 [27], RGS9 [28], and TLE1 [29]).”
Aurora Kinase B Expression, Its Regulation and Therapeutic Targeting in Human Retinoblastoma
Borah, N. A., Sradhanjali, S., Barik, M. R., Jha, A., Tripathy, D., Kaliki, S., Rath, S., Raghav, S. K., Patnaik, S., Mittal, R., et al. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.3.16 · Cited by 31
“10,19,20 To examine the role of MYCN in the regulation of AURKB expression, we first analyzed the promoter sequence of AURKB for the presence of MYCN binding motifs.”
Rb1 Haploinsufficiency Promotes Telomere Attrition and Radiation-Induced Genomic Instability
González-Vasconcellos, I., Anastasov, N., Sanli-Bonazzi, B., Klymenko, O., Atkinson, M. J., & Rosemann, M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3117 · Cited by 33
MR Imaging Features of Retinoblastoma: Association with Gene Expression Profiles
Jansen, R. W., de Jong, M. C., Kooi, I. E., Sirin, S., Göricke, S. L., Brisse, H. J., Maeder, P. P., Galluzzi, P., van der Valk, P., Cloos, J. J., et al. (2018) · Radiology · doi:10.1148/radiol.2018172000 · Cited by 30
Twists in views on RB functions in cellular signaling, metabolism and stem cells
Takahashi, C., Sasaki, N., & Kitajima, S. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02284.x · Cited by 33
The Critical Role of Ferroptosis in Hepatocellular Carcinoma
Pan, F., Lin, X., Hao, L., Wang, T., Song, H., & Wang, R. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.882571 · Cited by 32
González‐Moles, M. Á., Pino, C. K.-D., & Ramos‐García, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113099 · Cited by 34
Comprehensive Somatic Copy Number Analysis Using Aqueous Humor Liquid Biopsy for Retinoblastoma
Kim, M. E., Polski, A., Xu, L., Prabakar, R. K., Peng, C., Reid, M. W., Shah, R., Kühn, P., Cobrinik, D. E., Hicks, J. B., et al. (2021) · Cancers · doi:10.3390/cancers13133340 · Cited by 28
“Although the previously identified highly recurrent RB SCNAs remained the most prevalent among the 68 eyes analyzed here, specific non-highly recurrent RB SCNAs were also seen albeit at far lower rates; this is similar to past publications on tumor tissue [3,4,8,11,33]).”
BackgroundResultSingh, H. P., Shayler, D. W., Fernández, G. E., Thornton, M. E., Craft, C. M., Grubbs, B. H., & Cobrinik, D. E. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2200721119 · Cited by 29
Genome-wide changes accompanying the knockdown of Ep-CAM in retinoblastoma.
Mitra, M., Kandalam, M., Verma, R. S., UmaMaheswari, K., & Krishnakumar, S. (2010) · PubMed Central · Cited by 30
Retinoblastoma in Finland, 1964–2014: incidence and survival
Nummi, K., & Kivelä, T. (2020) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2019-315744 · Cited by 25
Retinoblastoma genetics in India: From research to implementation
Dimaras, H. (2015) · Indian Journal of Ophthalmology · doi:10.4103/0301-4738.156917 · Cited by 25
“[10] The relative degree of gains and losses distinguishes benign retinoma (less genomic instability) from malignant retinoblastoma (more genomic instability).[11] Additional genetic alterations during the development of retinoblastoma include deregulation of microRNAs, aberrant methylations, single nucleotide polymor…”
BackgroundSelf-citationThe switch from pRb/p105 to Rb2/p130 in DNA damage and cellular senescence
Helmbold, H., Galderisi, U., & Bohn, W. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22786 · Cited by 25
González‐Moles, M. Á., Warnakulasuriya, S., López-Ansio, M., & Ramos‐García, P. (2022) · Cancers · doi:10.3390/cancers14153834 · Cited by 28
Cooperation between Rb and Arf in suppressing mouse retinoblastoma
Conkrite, K. L., Sundby, M., Mu, D., Mukai, S., & MacPherson, D. P. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61403 · Cited by 25
“It was shown that retinoma, adjacent to normal retina and contiguous with malignant retinoblastoma, exhibited homozygous RB deletion but was nonpro-liferative (4).”
InfluentialMarkey, M. P. (2010) · Frontiers in bioscience · doi:10.2741/3780 · Cited by 28
Inhibition of Retinoblastoma Cell Growth by CEP1347 Through Activation of the P53 Pathway
Togashi, K., Okada, M., Suzuki, S., Sanomachi, T., Seino, S., Yamamoto, M., Yamashita, H., & Kitanaka, C. (2020) · Anticancer Research · doi:10.21873/anticanres.14499 · Cited by 23
Recurrent Somatic Chromosomal Abnormalities in Relapsed Extraocular Retinoblastoma
Aschero, R., Francis, J. H., Ganiewich, D., Gómez‐González, S., Sampor, C., Zugbi, S., Ottaviani, D., Lemelle, L., Mena, M. D., Winter, U., et al. (2021) · Cancers · doi:10.3390/cancers13040673 · Cited by 23
“In other tumors such as neuroblastoma, it has been debated if the CNA, leading to genomic instability, represent the driver for tumor progression and aggressiveness [26,35].”
BackgroundResultLi, Y.-P., Wang, Y., Wang, W., Zhang, X., Shen, R., Jin, K., Jin, L., & Jin, Z. (2022) · PNAS Nexus · doi:10.1093/pnasnexus/pgac162 · Cited by 28
“Although several cytogenetic and comparative genomic hybridization studies were used to show the insufficiency of RB1 inactivation for determining Rb, these are all based on the consequences of solid tumor, and they could not preclude that loss of RB1 function leads to genomic instability and even more “hits” (15, 16,…”
BackgroundGenetic screening in patients with Retinoblastoma in Israel
Sagi, M., Frenkel, A., Eilat, A., Weinberg, N., Frenkel, S., Pe’er, J., Abeliovich, D., & Lerer, I. (2015) · Familial Cancer · doi:10.1007/s10689-015-9794-z · Cited by 23
“When both copies of the RB1 gene are inactivated cell cycle progression is uncontrolled and followed by a set of genomic losses and gains that drives benign non-proliferative retinomas intomalignant retinoblastomas [8].”
BackgroundLong non‑coding RNA H19 regulates viability and metastasis, and is upregulated in retinoblastoma
Li, L., Chen, W., Wang, Y., Tang, L., & Han, M. (2018) · Oncology Letters · doi:10.3892/ol.2018.8385 · Cited by 24
Lin, F. Y. H., & Chintagumpala, M. (2021) · Clinics in Perinatology · doi:10.1016/j.clp.2020.12.001 · Cited by 26
Analysis of retinoblastoma age incidence data using a fully stochastic cancer model
Little, M. P., Kleinerman, R. A., Stiller, C. A., Li, G., Kroll, M. E., & Murphy, M. F. G. (2011) · International Journal of Cancer · doi:10.1002/ijc.26039 · Cited by 23
“In some cases, instead of RB, loss of RB1 leads to the benign lesion retinoma.(2,35) However, retinoma is rare—only present in 0.”
BackgroundGenetic perspective of retinoblastoma: From present to future
Madhavan, J., Khetan, V., & Mallipatna, A. C. (2016) · Indian Journal of Ophthalmology · doi:10.4103/0301-4738.185585 · Cited by 25
“progress to an active, malignant RB, perhaps by the failure of senescence.[25]”
BackgroundSelf-citationRB1 loss triggers dependence on ESRRG in retinoblastoma
Field, M. G., Kuznetsoff, J. N., Zhang, M. G., Dollar, J. J., Durante, M. A., Sayegh, Y., Decatur, C. L., Kurtenbach, S., Pelaez, D., & Harbour, J. W. (2022) · Science Advances · doi:10.1126/sciadv.abm8466 · Cited by 25
RB1 gene mutations and genetic spectrum in retinoblastoma cases
Ödemiş, D. A., Kebudi, R., Bayramova, J., Kılıç, S., Türkcan, G. K., Tunçer, Ş. B., Erdoğan, Ö. Ş., Çelik, B., Gültaslar, B. K., Bay, S. B., et al. (2023) · Medicine · doi:10.1097/md.0000000000035068 · Cited by 21
“RB1 loss has been reported to cause non-proliferative retinoma and subsequently triggers the progression of retinoblastoma with increased genomic instability.[28] Up to 45% of retinoblastomas have been reported to develop due to a mutation of the RB1 gene and is inherited to next generations, and these cases were show…”
BackgroundTumorspheres but Not Adherent Cells Derived from Retinoblastoma Tumors Are of Malignant Origin
Bond, W. S., Akinfenwa, P. Y., Perlaky, L., Hurwitz, M. Y., Hurwitz, R. L., & Chévez‐Barrios, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063519 · Cited by 20
“Only in very rare instances, such as in benign retinocytomas [29], do non-malignant cells lose all functioning pRb.”
Backgroundp16INK4a expression in retinoblastoma: a marker of differentiation grade
Liu, Y., Zhong, X., Wan, S., Zhang, W., Lin, J., Zhang, P., & Li, Y. (2014) · Diagnostic Pathology · doi:10.1186/s13000-014-0180-1 · Cited by 20
Kif14 overexpression accelerates murine retinoblastoma development
O’Hare, M., Shadmand, M., Sulaiman, R. S., Sishtla, K. L., Sakisaka, T., & Corson, T. W. (2016) · International Journal of Cancer · doi:10.1002/ijc.30221 · Cited by 20
“This readiness of Kif14 to promote growth once pRB is disabled in the murine retina echoes what is observed genetically in humans, in the transition from benign retinoma (which lacks functional pRB) to proliferating retinoblastoma, which also often harbors genomic gain and overexpression of KIF14.(2) In TAg-RB, the Ki…”
InfluentialSelf-citationSradhanjali, S., Rout, P., Tripathy, D., Kaliki, S., Rath, S., Modak, R., Mittal, R., Chowdary, T. K., & Reddy, M. M. (2021) · Cancers · doi:10.3390/cancers13205248 · Cited by 19
“The inactivation of both the alleles of RB1 initiates benign lesion, retinoma in the retina of the susceptible eye [7].”
BackgroundMOLECULAR KARYOTYPE OF SPORADIC UNILATERAL RETINOBLASTOMA TUMORS
Ganguly, A. A., Nichols, K. E., Grant, G. R., Rappaport, E. F., & Shields, C. L. (2009) · Retina · doi:10.1097/iae.0b013e3181a0be05 · Cited by 19
Libertini, S. J., Chen, H., Al-Bataina, B., Koilvaram, T., George, M. D., Gao, A. C., & Mudryj, M. M. (2011) · The Prostate · doi:10.1002/pros.21468 · Cited by 19
“However, increased E2F3 expression, along with a deletion of RB, resulted in the emergence of highly proliferative retinoblastomas [41].”
BackgroundE2F1/CKS2/PTEN signaling axis regulates malignant phenotypes in pediatric retinoblastoma
Chen, M., Zhao, Z., Wu, L., Huang, J., Yu, P., Qian, J., Ni, T., & Zhao, C. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05222-9 · Cited by 19
“Biallelic inactivation of RB1 is necessary but not sufficient for initiation of RB formation [2, 16].”
BackgroundTang, J., Liu, Y., Wang, Y., Zhang, Z., Nie, J., Wang, X., Ai, S., Li, J., Gao, Y., Li, C., et al. (2024) · Biomarker Research · doi:10.1186/s40364-024-00596-8 · Cited by 18
“Conversely, retinoma like cells showed a notable reduction in metabolic activity, which may be attributed to their low level of genomic instability and elevated expression of senescence-associated proteins [37].”
BackgroundDevelopment of zebrafish medulloblastoma-like PNET model by TALEN-mediated somatic gene inactivation
Shim, J., Choi, J., Park, M.-H., Kim, H., Kim, J.-H., Kim, S., Hong, D., Kim, S., Lee, J. E., Kim, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19424 · Cited by 20
p53, miR-34a and EMP1—Newly Identified Targets of TFF3 Signaling in Y79 Retinoblastoma Cells
Busch, M. A., Klein, S., Große-Kreul, J., Scheiner, O., Metz, K. A., Stephan, H., & Dünker, N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174129 · Cited by 17
“Retinal cells homozygous for RB1 loss can form benign tumors called retinomas, but further genomic changes are needed to form retinoblastoma [4].”
BackgroundKIF14 As An Oncogene In Retinoblastoma: A Target For Novel Therapeutics?
Basavarajappa, H. D., & Corson, T. W. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.158 · Cited by 19
Self-citationTherapeutic Targeting PLK1 by ON-01910.Na Is Effective in Local Treatment of Retinoblastoma
Ma, H., Nie, C., Chen, Y., Li, J., Xie, Y., Tang, Z., Gao, Y., Ai, S., Mao, Y., Sun, Q., et al. (2021) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504021x16130322409507 · Cited by 18
Animal models in retinoblastoma research
Nair, R. M., Kaliki, S., & Vemuganti, G. K. (2013) · Saudi Journal of Ophthalmology · doi:10.1016/j.sjopt.2013.06.008 · Cited by 19
“In Retinoblastoma, the loss of function of the RB1 gene initiates retinoma leading to genomic instability.(17) Retinomas with non-proliferative areas have extra copies of genes on chromosome 1q, that includes KIF14 and MDM4.”
BackgroundSmart Nanocarriers for the Treatment of Retinal Diseases
Liu, S., Yan, Z., Huang, Z., Yang, H., & Li, J. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c01289 · Cited by 16
Retinoblastoma: Recent trends A mini review based on published literature
Khetan, V., Gupta, A., & Gopal, L. (2011) · Oman Journal of Ophthalmology · doi:10.4103/0974-620x.91265 · Cited by 17
“…the precursor of RB. [29-33] Recently, it has been demonstrated that the two mutational events inactivating the RB1 gene are already present in RN. [31] A study by Dimaras et al in RN importantly clarified that the two hits in RB1 (M1–M2) do not inevitably cause a malignant phenotype but only…”
Self-citationThe Bcl-2/Bcl-XL inhibitor ABT-737 promotes death of retinoblastoma cancer cells
Allaman-Pillet, N., Oberson, A., Munier, F. L., & Schorderet, D. F. (2011) · Ophthalmic Genetics · doi:10.3109/13816810.2011.615077 · Cited by 16
High levels of global genome methylation in patients with retinoblastoma
Yazıcı, H., Wu, H., Tigli, H., Yilmaz, E., Kebudi, R., & Santella, R. M. (2020) · Oncology Letters · doi:10.3892/ol.2020.11613 · Cited by 16
“A study conducted by Dimaras et al (50) explored the molecular Table I. Distribution of global genome methylation levels in the tumor tissues (n=39) and peripheral blood (n=69) of patients with retinoblastoma and the peripheral blood of all healthy controls (n=44), including unaffected healthy…”
Barbosa, R. H., Aguiar, F. C. C., Silva, M. F. L., Costa, R. A., Vargas, F. R., Lucena, E., de Souza, M. C., de Almeida, L. M., Bittar, C. M., Ashton‐Prolla, P., et al. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-11686 · Cited by 16
Retinoma Underlying Retinoblastoma Revealed After Tumor Response to 1 Cycle of Chemotherapy
Dimaras, H. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.178 · Cited by 16
Self-citationShields, C. L., Srinivasan, A., Lucio-Alvarez, J. A., & Shields, J. A. (2021) · Journal of American Association for Pediatric Ophthalmology and Strabismus · doi:10.1016/j.jaapos.2020.11.024 · Cited by 15
Surgical Ophthalmic Oncology: A Collaborative Open Access Reference
Chaugule, S. S., Honavar, S. G., & Finger, P. T. (2019) · Springer eBooks · doi:10.1007/978-3-030-18757-6 · Cited by 22
Molecular diagnosis of retinoblastoma by circulating tumor DNA analysis
Jiménez, I., Frouin, É., Chicard, M., Dehainault, C., Gall, J. L., Benoist, C., Gauthier, A., Lapouble, E., Houdayer, C., Radvanyi, F., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.05.039 · Cited by 15
Rathore, S., Verma, A., Ratna, R., Marwa, N., Ghiya, Y., Honavar, S. G., Tiwari, A., Das, S., & Varshney, A. (2023) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_3172_22 · Cited by 18
“128 tumor tissue samples from enucleated eyes of RB patients (20/128 with retinoma) Gene‐specific FISH and qPCR Immunostaining and RT‐PCR NGFR, KIF14, MYCN, CDH11, DEK, and E2F3 Toronto, Canada and Philadelphia, USA Human Molecular Genetics, 2008[74]”
Utz, V. M., Brightman, D. S., Sandoval, M. A. M. D. O., Hufnagel, R. B., & Saal, H. M. (2020) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31839 · Cited by 14
Shurong, Z., & Cui, Z. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9686 · Cited by 14
Hülsenbeck, I., Frank, M., Biewald, E. M., Kanber, D., Lohmann, D. R., & Ketteler, P. (2021) · Cancers · doi:10.3390/cancers13071605 · Cited by 13
p53 Arg72Pro and MDM2 309 SNPs in hereditary retinoblastoma
Epistolato, M. C., Disciglio, V., Livide, G., Berchialla, P., Mencarelli, M. A., Marozza, A., Amenduni, M., Hadjistilianou, T., Francesco, S. D., Acquaviva, A., et al. (2011) · Journal of Human Genetics · doi:10.1038/jhg.2011.82 · Cited by 16
Stratégie thérapeutique du rétinoblastome Guide clinique canadien
(2009) · Canadian Journal of Ophthalmology · doi:10.1016/s0008-4182(09)80180-4 · Cited by 16
Update on the Treatment of Retinoblastoma
Manrique, M. M., Akinbolue, D., Madigan, W. P., & Bregman, J. A. (2021) · NeoReviews · doi:10.1542/neo.22-7-e423 · Cited by 13
Nie, C., Ma, H., Gao, Y., Li, J., Tang, Z., Chen, Y., & Lu, R. (2020) · Ophthalmologica · doi:10.1159/000506993 · Cited by 13
Parental Origin of the RB1 Gene Mutations in Families with Low Penetrance Hereditary Retinoblastoma
Alekseeva, E. A., Бабенко, О. В., Козлова, В. М., Ushakova, T. L., Kazubskaya, T. P., Nemtsova, M. V., Chesnokova, G. G., Mikhaylenko, D. S., Bure, I. V., Kalinkin, A. I., et al. (2021) · Cancers · doi:10.3390/cancers13205068 · Cited by 13
Lactoferrin and its nano-formulations in rare eye diseases
Singh, J., Sharma, M., Jain, N., Aftab, I., Vikram, N. K., Singh, T. P., Sharma, P. K., & Sharma, S. (2022) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_303_22 · Cited by 15
Ocular Expression and Distribution of Products of the POAG-Associated Chromosome 9p21 Gene Region
Chidlow, G., Wood, J. P. M., Sharma, S., Dimasi, D. P., Burdon, K. P., Casson, R. J., & Craig, J. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075067 · Cited by 13
“The results also concur with previous studies that have investigated p16 expression in retinoma [62] and retinoblastoma [63].”
ResultA Language for Retinoblastoma: Guidelines and Standard Operating Procedures
Valenzuela, A. A., Chan, H. S. L., Héon, E., & Gallie, B. L. (2010) · Springer eBooks · doi:10.1007/978-3-642-12041-1_9 · Cited by 15
Self-citationUBE2T/STAT3 Signaling Promotes the Proliferation and Tumorigenesis in Retinoblastoma
Xu, N., Cui, Y., Hong, S., Guo, G., Sun, F., Jian, T., & Rao, H. (2022) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.63.9.20 · Cited by 11
RetractedRetinoblastoma: Aqueous humor liquid biopsy
Sánchez, G. M., Chigane, D., Lin, M., Xu, L., Yellapantula, V. D., & Berry, J. L. (2025) · Taiwan Journal of Ophthalmology · doi:10.4103/tjo.tjo-d-24-00133 · Cited by 11
“[11,40,41] These genomic changes involve SCNAs, and common alterations in RB include gains in chromosome regions 1q, 2p, and 6p, and losses in regions 13q and 16q.”
Cutaneous pleomorphic fibromas arising in patients with germline TP53 mutations
Cloutier, J. M., Shalin, S. C., Lindberg, M. R., Gardner, J. M., Fernandez‐Pol, S., Zaba, L. C., Novoa, R. A., & Brown, R. A. (2020) · Journal of Cutaneous Pathology · doi:10.1111/cup.13686 · Cited by 11
“Similarly, benign retinomas from patients with germline Rb1 mutations strongly express p16, while malignant retinoblastomas lose p16 expression, suggesting that p16 is necessary for cellular senescence.(17) Overexpression of p16 in pleomorphic fibromas likely reflects a critical role for p16 in preventing progression…”
BackgroundBelikov, A. V., Vyatkin, A. D., & Leonov, S. V. (2021) · PeerJ · doi:10.7717/peerj.11976 · Cited by 11
“For example, it was shown that inactivation of both alleles of RB1 leads first to retinoma, a benign tumour with genomic instability that easily transforms to retinoblastoma upon acquiring additional mutations ( Dimaras et al., 2008 ).”
Retinoblastoma in Chinese Children Aged Five to Fourteen Years
Chang, Y., Shi, J., Zhao, J., Xu, X., Ma, J., Shen, L., Bai, H., Gao, F., Zhang, Z., Li, B., et al. (2015) · Ophthalmologica · doi:10.1159/000381220 · Cited by 11
Stagner, A. M., & Jakobiec, F. A. (2016) · Seminars in Ophthalmology · doi:10.3109/08820538.2015.1115257 · Cited by 11
“deletion of certain genes, initiates malignancy and uncontrolled proliferation.(15) The RB1 protein has now been established to maintain chromosomal stability, while its loss allows for mutations in key cancer pathways.”
BackgroundNadiarnykh, O., Badalova, N. A., Gaillard, M., Bosscha, M. I., Fabius, A. W. M., Verbraak, F. D., Munier, F. L., de Boer, J. F., & Moll, A. C. (2019) · Acta Ophthalmologica · doi:10.1111/aos.14214 · Cited by 11
“While retinoblastoma is a rapidly growing malignancy, retinoma is a benign retinal tumour characterized by the absence of growth or shrinkage over time (Dimaras et al. 2008; Shah et al. 2011).”
BackgroundBioinformatics analyses of retinoblastoma reveal the retinoblastoma progression subtypes
Cao, M., Wang, S., Zou, J., & Wang, W. (2020) · PeerJ · doi:10.7717/peerj.8873 · Cited by 11
“It has also been advised that differentiated areas in RB are likely benign precursor lesions of the undifferentiated areas (Dimaras et al., 2008).”
BackgroundMolecular alterations in retinoblastoma beyond RB1
Mendonça, V., Evangelista, A. C., Matta, B. P., Moreira, M. Â. M., de Faria, P. A. S., Lucena, E., & Seuánez, H. N. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2021.108753 · Cited by 11
Cancer Associated PRDM9: Implications for Linking Genomic Instability and Meiotic Recombination
Ladias, P., Markopoulos, G. S., Kostoulas, C., Bouba, I., Markoula, S., & Georgiou, I. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216522 · Cited by 10
“Importantly, tumor-suppressor factors such as CDH1 ansd CDH11 are associated with genomic stability [25,26].”
BackgroundAssociation of MTHFR 677C>T, 1298A>C and MTR 2756A>G Polymorphisms with Risk of Retinoblastoma
Gohari, M., Dastgheib, S. A., Nedooshan, J. J., Akbarian-Bafghi, M. J., Morovati-Sharifabad, M., Mirjalili, S. R., & Neámatzadeh, H. (2019) · Klinicka onkologie · doi:10.14735/amko2019375 · Cited by 10
“However, with the continued development of medical genetics, an increas ing number of studies have focused on the identification of RB genetic bio markers such as gene polymorphisms, oncogenes (KIF14, MDM4, E2F3, MYCN and DEK), potential tumour suppressors (NGFR and CDH11), microRNA and long non-coding RNA [7,9].”
BackgroundGenomic instability and eye diseases
Liu, H., Cheng, J., Zhuang, X., Qi, B., Li, F. F., & Zhang, B. N. (2023) · Advances in Ophthalmology Practice and Research · doi:10.1016/j.aopr.2023.03.002 · Cited by 10
“23,24 High ARF expression is observed in both RB1 -de fi cient retina and precancerous retina, 25 indicating that the p19 Arf -mediated apoptotic response may be impaired in the early stages of RB tumorigenesis.”
BackgroundZhang, Y., Wang, Y.-Z., Zhi, T., Jin, M., Huang, D., & Ma, X. (2023) · BMC Pediatrics · doi:10.1186/s12887-023-03984-5 · Cited by 10
“6% (17/373), and the occurrence of RB in other children may be related to secondary mutation [32].”
BackgroundMolecular pathology of retinoblastoma
Biswas, J., Kandalam, M., Mitra, M., & Subramanian, K. (2010) · Middle East African Journal of Ophthalmology · doi:10.4103/0974-9233.65498 · Cited by 11
Observations on spontaneous tumor formation in mice overexpressing mitotic kinesin Kif14
Sishtla, K. L., Pitt, N., Shadmand, M., O’Hare, M., Sulaiman, R. S., Sinn, A. L., Condon, K. W., Pollok, K. E., Sandusky, G. E., & Corson, T. W. (2018) · Scientific Reports · doi:10.1038/s41598-018-34603-4 · Cited by 10
Self-citationAllaman-Pillet, N., Oberson, A., & Schorderet, D. F. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0253 · Cited by 11
“PI3K/AKT, JAK-STAT, p53, progressively lead to resistance of retinoblastoma cells to death (2-5).”
BackgroundRetinoblastoma Tumorigenesis: Genetic and Epigenetic Changes Walk Hand in Hand
Ketteler, P., Corson, T. W., & Lohmann, D. R. (2012) · Future Oncology · doi:10.2217/fon.12.41 · Cited by 12
Self-citationRetinocytoma Shows Lack of Response to Chemoreduction
Chung, J., Turaka, K., & Shields, C. L. (2010) · Journal of Pediatric Ophthalmology & Strabismus · doi:10.3928/01913913-20101217-03 · Cited by 10
Cobrinik, D. E. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.07.023 · Cited by 10
Challenges for Early Diagnosis in Retinoblastoma in Low‐ and Middle‐Income Countries
Chantada, G. L., Villanueva, G. A., & Abramson, D. H. (2025) · Pediatric Blood & Cancer · doi:10.1002/pbc.31859 · Cited by 9
“It is postulated that retinoma can represent the first event caused by an RB1 gene mutation, upon which other genomic alterations occur in cells with genomic instability, leading to a progression into a more malignant tumor [23].”
Identification and expression of a novel MDM4 splice variant in human glioma
Wang, X., Sheng, P. X., Guo, X., Wang, J., Hou, L.-J., Hu, G., Luo, C., Dong, Y., & Lu, Y. (2013) · Brain Research · doi:10.1016/j.brainres.2013.07.054 · Cited by 9
Knudson to embryo selection: A story of the genetics of retinoblastoma
Khetan, V., & Athavale, V. (2018) · Taiwan Journal of Ophthalmology · doi:10.4103/tjo.tjo_37_18 · Cited by 10
“examined eyes enucleated for RB for underlying retinoma, and showed the first molecular evidence of progression of senescent retinoma to RB.[26] RB1 gene is known to be essential for chromosomal stability, and RB1 inactivation promotes a state of genomic instability.”
BackgroundMethodSelf-citationRecent Advances in Understanding the Role of Autophagy in Paediatric Brain Tumours
Gatto, F., Milletti, G., Carai, A., Mastronuzzi, A., & Nazio, F. (2021) · Diagnostics · doi:10.3390/diagnostics11030481 · Cited by 9
Priest, J. R. (2011) · Pediatric oncology · doi:10.1007/978-3-642-04197-6_25 · Cited by 9
Etiology including epigenetic defects of retinoblastoma
Zhou, L., Tong, Y., Ho, B. M., Li, J., Chan, H. Y. E., Zhang, T., Du, L., He, J. N., Chen, L. J., Tham, C. C. Y., et al. (2024) · Asia-Pacific Journal of Ophthalmology · doi:10.1016/j.apjo.2024.100072 · Cited by 10
ROUTINE FUNDUS SCREENING OF FAMILIES OF CHILDREN WITH RETINOBLASTOMA
Kaliki, S., Rathi, S. G., & Patel, A. (2018) · Retina · doi:10.1097/iae.0000000000002134 · Cited by 8
del Río, N. R., Gómez, J. M. A., de la Rosa, F. J. A. G., Calvo, J. M. P., & Martin, A. (2013) · Archivos de la Sociedad Española de Oftalmología · doi:10.1016/j.oftal.2013.07.006 · Cited by 8
MacFarlane, L.-A., & Murphy, P. R. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20686 · Cited by 12
“22 Rb1 Cell-cycle progression; proliferation Tumorigenesis; tumor growth; invasion; metastasis; aggressiveness [77] þ3.”
Chiasmatic Infiltration Secondary to Late Malignant Transformation of Retinoma
Mataftsi, A., Zografos, L., Balmer, A., Uffer, S., Stupp, R., Janzer, R. C., Pica, A., Schorderet, D. F., & Munier, F. L. (2011) · Ophthalmic Genetics · doi:10.3109/13816810.2011.575431 · Cited by 8
MONOGENIC DISORDERS: AN OVERVIEW.
Babar, U. (2017) · International Journal of Advanced Research · doi:10.21474/ijar01/3294 · Cited by 9
Gu, H., Zhang, Z., Xiao, Y.-S., Shen, R., Jiang, H.-C., Ren-qiu, L., Li, R.-Q., Yang, X.-H., Gu, H.-Y., He, W., et al. (2020) · BMC Medical Genetics · doi:10.1186/s12881-020-01150-7 · Cited by 8
Zou, Y., Li, J.-K., Hua, P., Liang, T., Ji, X., & Zhao, P. (2021) · PubMed Central · Cited by 8
Histone Deacetylases in Retinoblastoma
Lisek, M., Tomczak, J., Swiatek, J., Kaluza, A., & Boczek, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136910 · Cited by 9
“However, the mere loss of RB1 does not seem to be enough to initiate tumor malignancy, as benign retinomas also display loss of both RB1 alleles [17].”
BackgroundJiang, Z., Allkanjari, M. S., Chung, P. E. D., Tran, H., Ghanbari-Azarnier, R., Wang, D., Lin, D. C. C., Min, J. Y., Ben‐David, Y., & Zacksenhaus, E. (2025) · Cancers · doi:10.3390/cancers17050720 · Cited by 7
“Additional alterations including reduction in p16 INK4B and p130 levels, loss of the tumor suppressor genes CDH11 and p75NTR, and copy number gain and high expression of the oncogenes MYCN, E2F3, DEK, KIF14 and MDM4, can induce clonal expansion and full-blown retinoblastoma [151].”
Garoon, R. B., Medina, C. A., Scelfo, C., & Harbour, J. W. (2018) · Retinal Cases & Brief Reports · doi:10.1097/icb.0000000000000732 · Cited by 7
Distinct Signatures of Genomic Copy Number Variants Define Subgroups of Merkel Cell Carcinoma Tumors
Hill, N. T., Kim, D., BUSAM, K. J., Chu, E. Y., Green, C., & Brownell, I. (2021) · Cancers · doi:10.3390/cancers13051134 · Cited by 7
Gallie, B. L., & Soliman, S. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6616-0.00043-8 · Cited by 7
Self-citationTargeting ALDOA to modulate tumorigenesis and energy metabolism in retinoblastoma
Wang, Y., Tang, J., Liu, Y., Zhang, Z., Zhang, H., Ma, Y., Wang, X., Ai, S., Mao, Y., Zhang, P., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110725 · Cited by 11
“28 The specific high expression of ALDOA within these three cell types suggests its potential oncogenic role in RB.”
Tang, J., Liu, Y., Zhang, Z., Ren, Y., Ma, Y., Wang, Y., Li, J., Gao, Y., Li, C., Cheng, C., et al. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.1.31 · Cited by 6
“36 The heterogeneity in MCM complex member expression across various cell types within RB sheds light on their diverse functional roles within the tumor microenvironment.”
Metadata
- Authors
- Dimaras, H., Khetan, V., Halliday, W., Orlic, M., Prigoda, N. L., Piovesan, B., Marrano, P., Corson, T. W., Eagle, R. C., Squire, J. A., & Gallie, B. L.
- Affiliations
- University of Toronto (CA)
- Hospital for Sick Children (CA)
- University Health Network (CA)
- Princess Margaret Cancer Centre (CA)
- Wills Eye Hospital (US)
- Corresponding author
- Gallie, Brenda L.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-01-22
- Volume
- 17
- Issue
- 10
- Pages
- 1363-1372
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2122129374
- Cited by
- 351
- References
- 48
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 20 · 2023: 15 · 2022: 24 · 2021: 36 · 2020: 19 · 2019: 19 · 2018: 16 · 2017: 14 · 2016: 12 · 2015: 23 · 2014: 14 · 2013: 20 · 2012: 19
- FWCI
- 24.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ocular Oncology and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- retinoblastoma, retinoma, genomic instability, cellular senescence, p16INK4a, p130, two-hit model, tumor suppressor, oncogene expression, aneuploidy, MYCN, E2F3, DEK, KIF14, MDM4, cadherin-11, p75 neurotrophin receptor, retinal development, tumor progression
- MeSH terms
- Adult, Gene Amplification, Homozygote, Humans, Infant, Male, Retinoblastoma, Oncogene Proteins, Tumor Suppressor Protein p53, Retinoblastoma Protein, Disease Progression, Gene Dosage, Proliferating Cell Nuclear Antigen, Ki-67 Antigen, Cyclin-Dependent Kinase Inhibitor p16, Gene Silencing, Tumor Suppressor Proteins, Genomic Instability, Cell Proliferation, Retinoblastoma-Like Protein p130
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.